Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation

Journal of Translational Medicine

Volumn 6, Issue , 2008, Pages

  Pacanowski, Michael A ^a   Zineh, Issam ^a   Li, Haihong ^b   Johnson, Delia B ^c   Cooper DeHoff, Rhonda M ^b   Bittner, Vera ^d   McNamara, Dennis M ^e   Sharaf, Barry L ^f   Bairey Merz, Noel C ^g   Pepine, Carl J ^b   Johnson, Julie A ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f RHODE ISLAND HOSPITAL   (United States)

^g CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; ADRENERGIC RECEPTOR; G PROTEIN BETA3 SUBUNIT; G-PROTEIN BETA3 SUBUNIT; GNAS PROTEIN, HUMAN; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; MEMBRANE PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ADRENERGIC ACTIVITY; ADRENERGIC SYSTEM; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; COMORBIDITY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PROTEIN VARIANT; RISK ASSESSMENT; STROKE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; GENE FREQUENCY; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; RACE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL;

AGED; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; CONTINENTAL POPULATION GROUPS; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENOTYPE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MEMBRANE PROTEINS; MIDDLE AGED; MYOCARDIAL ISCHEMIA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; RECEPTORS, ADRENERGIC; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-3; RISK FACTORS;

EID: 42549111584     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-6-11     Document Type: Article

References (34)

1. Rosamond W Flegal K Friday G Furie K Go A Greenlund K Haase N Ho M Howard V Kissela B Kittner S Lloyd-Jones D McDermott M Meigs J Moy C Nichol G O'Donnell C J Roger V Rumsfeld J Sorlie P Steinberger J Thom T Wasserthiel-Smoller S Hong Y Heart Disease and Stroke Statistics - 2007 Update. A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 2006
2. Sharaf BL Pepine CJ Kerensky RA Reis SE Reichek N Rogers WJ Sopko G Kelsey SF Holubkov R Olson M Miele NJ Williams DO Merz CN Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory) Am J Cardiol 2001, 87(8):937-41; A3 10.1016/S0002-9149(01)01424-2 11305981
3. Panting JR Gatehouse PD Yang GZ Grothues F Firmin DN Collins P Pennell DJ Abnormal Subendocardial Perfusion in Cardiac Syndrome X Detected by Cardiovascular Magnetic Resonance Imaging N Engl J Med 2002, 346(25):1948-1953 10.1056/NEJMoa012369 12075055
4. Buchthal SD den Hollander JA Merz CN Rogers WJ Pepine CJ Reichek N Sharaf BL Reis S Kelsey SF Pohost GM Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms N Engl J Med 2000, 342(12):829-835 10.1056/ NEJM200003233421201 10727587
5. Quyyumi AA Women and ischemic heart disease: Pathophysiologic implications from the Women's Ischemia Syndrome Evaluation (WISE) Study and future research steps J Am Coll Cardiol 2006, 47(3 Suppl);S66-71 10.1016/j.jacc.2004.11.075 16458175
6. Johnson BD Shaw LJ Buchthal SD Bairey Merz CN Kim HW Scott KN Doyle M Olson MB Pepine CJ den Hollander J Sharaf B Rogers WJ Mankad S Forder JR Kelsey SF Pohost GM Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Circulation 2004, 109(24):2993-2999 10.1161/01.CIR.0000130642.79868.B2 15197152
7. Sesso HD Lee IM Gaziano JM Rexrode KM Glynn RJ Buring JE Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women Circulation 2001, 104(4):393-398 10.1161/ hc2901.093115 11468199
8. Cambien F Tiret L Genetics of cardiovascular diseases: From single mutations to the whole genome Circulation 2007, 116(15):1714-1724 10.1161/CIRCULATIONAHA.106.661751 17923582
9. Lanfear DE Jones PG Marsh S Cresci S McLeod HL Spertus JA Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome Jama 2005, 294(12):1526-1533 10.1001/jama.294.12.1526 16189366
10. Beitelshees AL Gong Y Wang D Schork NJ Cooper-Dehoff RM Langaee TY Shriver MD Sadee W Knot HJ Pepine CJ Johnson JA KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST) Pharmacogenet Genomics 2007, 17(9):719-729 17700361
11. Lanfear DE Jones PG Marsh S Cresci S Spertus JA McLeod HL Connexin37 (GJA4) genotype predicts survival after an acute coronary syndrome Am Heart J 2007, 154(3):561-566 10.1016/j.ahj.2007.04.059 17719307
12. Schuit SC Oei HH Witteman JC Geurts van Kessel CH van Meurs JB Nijhuis RL van Leeuwen JP de Jong FH Zillikens MC Hofman A Pols HA Uitterlinden AG Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction Jama 2004, 291(24):2969-2977 10.1001/jama.291.24.2969 15213208
13. Kirstein SL Insel PA Autonomic Nervous System Pharmacogenomics: A Progress Report Pharmacol Rev 2004, 56(1):31-52 10.1124/pr.56.1.2 15001662
14. Bairey Merz CN Kelsey SF Pepine CJ Reichek N Reis SE Rogers WJ Sharaf BL Sopko G for the WSG The Women's Ischemia Syndrome Evaluation (WISE) Study: Protocol design, methodology and feasibility report J Am Coll Cardiol 1999, 33(6):1453-1461 10.1016/S0735-1097(99)00082-0 10334408
15. Stephens M Scheet P Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation Am J Hum Genet 2005, 76(3):449-462 1196397 15700229 10.1086/428594
16. Ruczinski I Kooperberg C LeBlanc M Logic regression Journal of Computational and Graphical Statistics 2003, 12(3):475-511 10.1198/ 1061860032238
17. Kooperberg C Bis JC Marciante KD Heckbert SR Lumley T Psaty BM Logic regression for analysis of the association between genetic variation in the renin-angiotensin system and myocardial infarction or stroke Am J Epidemiol 2007, 165(3):334-343 10.1093/aje/kwk006 17082497
18. The Comprehensive R Archive Network [cran.r-project.org]
19. Kip KE Marroquin OC Shaw LJ Arant CB Wessel TR Olson MB Johnson BD Mulukutla S Sopko G Merz CN Reis SE Global inflammation predicts cardiovascular risk in women: A report from the Women's Ischemia Syndrome Evaluation (WISE) study Am Heart J 2005, 150(5):900-906 10.1016/ j.ahj.2005.02.002 16290958
20. Mason DA Moore JD Green SA Liggett SB A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor J Biol Chem 1999, 274(18):12670-12674 10.1074/jbc.274.18.12670 10212248
21. Iwai C Akita H Kanazawa K Shiga N Terashima M Matsuda Y Takai E Miyamoto Y Shimizu M Kajiya T Hayashi T Yokoyama M Arg389Gly polymorphism of the human beta1-adrenergic receptor in patients with nonfatal acute myocardial infarction Am Heart J 2003, 146(1):106-109 10.1016/ S0002-8703(03)00110-8 12851615
22. Mialet Perez J Rathz DA Petrashevskaya NN Hahn HS Wagoner LE Schwartz A Dorn GW Liggett SB Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure Nat Med 2003, 9(10):1300-1305 10.1038/nm930 14502278
23. White HL Maqbool A McMahon AD Yates L Ball SG Hall AS Balmforth AJ An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals at risk of coronary events. A WOSCOPS substudy Eur Heart J 2002, 23(14):1087-1092 10.1053/euhj.2001.3037 12090746
24. Akhter SA D'Souza KM Petrashevskaya NN Mialet-Perez J Liggett SB Myocardial beta1-adrenergic receptor polymorphisms affect functional recovery after ischemic injury Am J Physiol Heart Circ Physiol 2006, 290(4):H1427-32 10.1152/ajpheart.00908.2005 16537791
25. Pietri-Rouxel F St John Manning B Gros J Strosberg AD The biochemical effect of the naturally occurring Trp64→Arg mutation on human beta3-adrenoceptor activity Eur J Biochem 1997, 247(3):1174-1179 10.1111/ j.1432-1033.1997.01174.x 9288945
26. Higashi K Ishikawa T Ito T Yonemura A Shige H Nakamura H Association of a genetic variation in the beta 3-adrenergic receptor gene with coronary heart disease among Japanese Biochem Biophys Res Commun 1997, 232(3):728-730 10.1006/bbrc.1997.6339 9126344
27. Morrison AC Brancati FL Folsom AR Smith L Boerwinkle E Beta3-adrenergic receptor Trp64Arg polymorphism does not predict incident CHD or carotid intima-media thickness in a community-based sample of whites: The ARIC study. Atherosclerosis Risk in Communities Hum Genet 1999, 105(4):314-319 10.1007/s004390051107 10543398
28. Stangl K Cascorbi I Laule M Stangl V Meisel C Wernecke KD Ziemer S Baumann G Roots I Hauner H The beta3-adrenergic receptor Trp64Arg mutation is not associated with coronary artery disease Metabolism 2001, 50(2):184-188 10.1053/meta.2001.20179 11229427
29. Zafarmand MH van der Schouw YT Grobbee DE de Leeuw PW Bots ML T64A polymorphism in beta3-adrenergic receptor gene (ADRB3) and coronary heart disease: A case-cohort study and meta-analysis J Intern Med 2008, 263(1):79-89 18088254
30. Rozec B Gauthier C beta3-adrenoceptors in the cardiovascular system: putative roles in human pathologies Pharmacol Ther 2006, 111(3):652-673 10.1016/j.pharmthera.2005.12.002 16480771
31. Terra SG McGorray SP Wu R McNamara DM Cavallari LH Walker JR Wallace MR Johnson BD Bairey Merz CN Sopko G Pepine CJ Johnson JA Association between beta-adrenergic receptor polymorphisms and their G-protein-coupled receptors with body mass index and obesity in women: A report from the NHLBI-sponsored WISE study Int J Obes (Lond) 2005, 29(7):746-754 10.1038/sj.ijo.0802978 15917856
32. Dessy C Moniotte S Ghisdal P Havaux X Noirhomme P Balligand JL Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization Circulation 2004, 110(8):948-954 10.1161/ 01.CIR.0000139331.85766.AF 15302798
33. Steinle JJ Booz GW Meininger CJ Day JN Granger HJ Beta 3-adrenergic receptors regulate retinal endothelial cell migration and proliferation J Biol Chem 2003, 278(23):20681-20686 10.1074/jbc.M300368200 12670949
34. Reis SE Holubkov R Conrad Smith AJ Kelsey SF Sharaf BL Reichek N Rogers WJ Merz CN Sopko G Pepine CJ Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: Results from the NHLBI WISE study Am Heart J 2001. 141(5):735-741 10.1067/mhj.2001.114198 11320360